Enhanced Liver Fibrosis Score Stratifies Hepatocellular Carcinoma Risk in Patients With Hepatitis B Surface Antigen Seroclearance

被引：3
|
作者：
Mak, Lung-Yi [1 ,2 ]
Cheung, Ka-Shing [1 ,3 ]
Hui, Rex Wan-Hin [1 ]
Wong, Danny Ka-Ho [1 ,2 ]
Fung, James [1 ,2 ]
Yuen, Man-Fung [1 ,2 ]
Seto, Wai-Kay [1 ,2 ,3 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam Rd 102, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Med, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 12期
关键词：
hepatitis B virus (HBV); enhanced liver fibrosis (ELF); functional cure; hepatocellular carcinoma ( HCC); HBSAG SEROCLEARANCE;
D O I：
10.1093/cid/ciac387
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In this prospective study involving 337 chronic hepatitis B patients who achieved spontaneous hepatitis B surface antigen (HBsAg) seroclearance (SC), serum enhanced liver fibrosis (ELF) before SC was associated with hepatocellular carcinoma (HCC) (hazard ratio 2.588), and ELF 97% reduction in risk of HCC development in patients with age SC >= 50 (n = 190).
引用
收藏
页码：2257 / 2259
页数：3
相关论文
共 50 条
  • [1] Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance
    Mak, Lung Yi Loey
    Cheung, Ka-Shing
    Hui, Rex Wan-Hin
    Wong, Danny Ka-Ho
    Fung, Yan Yue James
    Yuen, Man-Fung
    Seto, Wai-Kay
    JOURNAL OF HEPATOLOGY, 2022, 77 : S273 - S274
  • [2] Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
    Park, Yewan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Park, Jun Yong
    Kim, Minseok Albert
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Do Young
    Ahn, Sang Hoon
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [3] Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma
    Song, Ci
    Zhu, Jian
    Ge, Zijun
    Yu, Chengxiao
    Tian, Ting
    Wang, Hui
    Han, Jing
    Shen, Hongbing
    Dai, Juncheng
    Lu, Jianquan
    Hu, Zhibin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1204 - 1206
  • [4] Estimation of hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Park, Yewan
    Oh, Joo Hyun
    Goh, Myungji
    Sinn, Dong Hyun
    Kim, Jihye
    Gwak, Geum-Yon
    Paik, Seung Woon
    Kang, Wonseok
    Paik, Yong-Han
    Choi, Moon Seok
    Kim, Minseok Albert
    Lee, Jeonghoon
    JOURNAL OF HEPATOLOGY, 2020, 73 : S399 - S399
  • [5] Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Huang, Rui
    Liu, Yong
    Wang, Jian
    Xia, Juan
    Yan, Xiaomin
    Wu, Chao
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 207 - 208
  • [6] Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Jiang, J. -F.
    Sun, J.
    Shi, J.
    Liu, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1286 - 1288
  • [7] Establishment of Hepatocellular Carcinoma Risk Prediction Model in Chronic Hepatitis B Patients with Hepatitis B Surface Antigen Seroclearance
    Nam, Heechul
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 81 (02): : 104 - 107
  • [8] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Yang, Hyun
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    Jang, Jeong Won
    JOURNAL OF HEPATOLOGY, 2022, 77 (03) : 632 - 641
  • [9] ANTIVIRAL THERAPY AND RISK FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Lee, Han Ah
    Kim, Seung Up
    Kim, Beom Kyung
    Ahn, Sang Hoon
    Lee, Hyun Woong
    Kim, Ja Kyung
    Sinn, Dong Hyun
    Seo, Yeon Seok
    HEPATOLOGY, 2023, 78 : S449 - S450
  • [10] A RISK PREDICTION MODEL FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Yang, Hyun
    Jang, Jeong Won
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Lee, Ahlim
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2022, 76 : S238 - S238
12345